delta-philanthotoxin has been researched along with muromonab-cd3 in 1 studies
Studies (delta-philanthotoxin) | Trials (delta-philanthotoxin) | Recent Studies (post-2010) (delta-philanthotoxin) | Studies (muromonab-cd3) | Trials (muromonab-cd3) | Recent Studies (post-2010) (muromonab-cd3) |
---|---|---|---|---|---|
63 | 0 | 11 | 85 | 1 | 50 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hablitz, JJ; Mathew, SS | 1 |
1 other study(ies) available for delta-philanthotoxin and muromonab-cd3
Article | Year |
---|---|
Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex.
Topics: Animals; Boron Compounds; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Inositol 1,4,5-Trisphosphate Receptors; Kainic Acid; Macrocyclic Compounds; Neocortex; Neurons; Nicotinic Antagonists; Oxazoles; Patch-Clamp Techniques; Polyamines; Presynaptic Terminals; Rats | 2008 |